A phase I study of ATR inhibitor gartisertib (M4344) as a single agent and in combination with carboplatin in patients with advanced solid tumours. - Burris, Howard A.; Berlin, Jordan; Arkenau, Tobias; Cote, Gregory M.; Lolkema, Martijn P.; Ferrer-Playan, Jordi; Kalapur, Anup; Bolleddula, Jayaprakasam; Locatelli, Giuseppe; Goddemeier, Thomas; Gounaris, Ioannis; de Bono, Johann (British Journal of Cancer, 2024)